This report presents the results of noncancer dose-response modeling for inhalation and oral exposures to nickel compounds using the NOAEllLOAEL and benchmark dose (BMD) approaches. Several key issues associated with the implementation of the BMD approach were examined. Primary among them are difficulties associated with use of data for which the dose-response shape is poorly defined: nonuniqueness of maximum likelihood estimates and lower bounds equal to zero. In addition, several generalizable properties of the "hybrid approach" for modeling continuous endpoints were identified. A hybrid modeling approach allows one to consider "biological significance" on an individual (rather than group) basis; differences between individual-and group-based biological significance in the definition of benchmark response (BMR) levels are elucidated. In particular, it is shown that BMOs defined using group-based BMRs may be more like LOAELs than NOAELs. Application of cross-chemical and cross-endpoint comparisons suggest that, for chronic inhalation exposure, nickel sulfate appears to be as toxic or more toxic than nickel subsulfide and nickel oxide, although the high response rates for the latter two compounds at the lowest chronically administered concentration make such conclusions problematic. A nickel reference concentration could be derived based on the most sensitive benchmark concentration for chronic inhalation exposure to nickel sulfate, 1.7 x 10-3 mg Ni/m3 for lung fibrosis in male rats. Analyses of oral studies of nickel sulfate and nickel chloride suggest that an appropriate basis for the nickel oral reference dose would be a BMD of 4-5 mg Ni/kg/day, based on increased prenatal mortality. (Uncertainty factors were not determined and neither an RfD nor an RfC was derived in this paper.) The BMD approach provides appropriate quantitative support for Nickel exposure occurs occupationally, primarily via the inhalation route, and through contamination of ambient air, most often as nickel oxide and nickel sulfate. Oral exposure of the general public to nickel is primarily in food. but may also occur via contaminated water (NIP, 1996a,b,c) . Nickel is one of the most frequently occurring chemicals in waste site... in the United States. Differences in the inhalation toxicity of the different nickel c0m-pounds con-elate with differences in their solubility (Dunnick et al.. 1988) , presumably due to differences in die cellular absorption of the deposited material. The respiratory tract is the primary target of inhaled nickel compounds, indicating substantial portaIof -entry effects (Dunnick et aL. 1988 (Dunnick et aL. , 1989 Benson et at. 1987 Benson et at. , 1988 Lovelace Inhalation Toxicology Resemch Institute, 1986a,b; NTP, 1996a,b,c) . Due to the relative size of cross-species (k)Simetric adjustments for respiratory and extrarespiratory effects (USEP A, 1994) , systemic effects reported by Benson et aI. (1987 Benson et aI. ( , 1988 and Dunnick et aI. (1988) occur at higher human equivalent concenttations than those inducing respiratory effects.
Subchronic, chronic, reproductive, and developmental studies of oral exposure to nickel compounds are available. In contrast to the inhalation route, ingested soluble nickel compounds are dissociated in the stomach. Therefore, the toxicity of different soluble nickel compounds should depend primarily on the amount of nickel absorbed. The two compounds evaluated in oral studies (nickel chloride and nickel sulfate) have similar water solubilities. Decreased body weight was the most sensitive endpoint in the subchronic study (American Biogenics Corporation, 1988) and the chronic study (Ambrose et al.. 1976) investigating general systemic effects. One subchronic study investigated the effects of nickel on the immune system (Dieter et al.. 1988 ). Reproductive and developmental toxicity studies [Smith et al. (1993) and Research Triangle Institute (1988) , respectively] reported decreased fetal and pup viability. I The work described in this article was SUpported by the U.S. Environmental ~on Agency (under Contract 68-D2-O129). The views expressed in this paper are those of d1e aulhon and do ~ necessarily reflect the views or policies of die U.S. Environmental Protection Agency. Mention of trade names or ~ products does not constitUte endorse~nt or ~mendatiOD for use.
2 Presented in part at the annual meeting of the Society for Risk Analysis, Adjustment for discontinuous exposure. to derive conAiRUCXIS eXJXl8Ure ~uiv-aleIIts. was peIf~ uling d~ Ã mbrose et al. (1976) also descrilJed a three-generation reproductive sttKIy in rats. SclIroeder and Mitchener (1971) conducted a three-generation study of rats administered nickel at 5 ppm (estimated at 0.43 mg Ni/kg/day), and observed significantly increased neonatal mortality and incidence of runts. However, this study is limited by the small sample size and by dietary insufficiency of odler trace elements, particularly chromium, which n\BY have contributed to toxicity of nickel (IRIS, 1997) .
The benchmark. doseJbenchrnark. concentration (BMDI BMC) approach has been proposed as an alternative to the NOAEULOAEL metl.od for noncancer risk assessment (Cnamp, 1984) . Advantages of the BMD approach over the NOAEULOAEL metI.od have been documented in several publications (Crump, 1984; Kimmel and Gaylor, 1988; Barnes et aI., 1995) , and include reduced dependency on ~ selection and dose spacing. more appropriate reflection of sample size, and better inclusion of dose-response inf~on. US EPA guidelines for risk assessment of developmental toxicity (USEPA, 1991) and reproductive toxicity (US EPA , I 996a). gui«klines for devel~ment of inhalation reference concentrations (RfCs) (USEPA, 1994) , and proposed guidelines for neurotoxicity risk assessment (USEPA, 1995) have addressed the awlication of BMD methodology. Indeed. several reference doses (Rms) and reference concentrations (RfCs) listed on EPA's Integrated Risk Information System (IRIS) have been developed using BMD ~Iogy, including the methylmercury RJD, and the carbon disulfide, antimony trioxide, aOO 1,1,1,2-tetrafluoroethane (HPC-134a) RfCs (IRIS, 1997) .
A few studies have been published describing tile benchmark. dose modeling of individual dlemicals, including 1,2-dibromo-3-chI(X"O()ropane (DBCP) (pease et al., 1991) , hydrogen fluoride (Alexeeff et al., 1993) , chromium (Maisch et al., 1994) , trichlonahylene (Haag-GrOnlund et aI., 1995) , and boric acid (Allen et al., 1996) . However, few of these studies have described issues related to the choice of endpoints to model or inteqJrelation of the results. The BMD/BMC modeling of inhalation and oral exposure to nickel described in this report is part of a series of chemical-specific case studies, one goal of which is the devel~ment of procedures appropriate for noncancer risk assessments using the BMD methodology. Of particular interest for the nickel case study is consideration of rational operational procedures for selecting endpoints for noncancer risk assessment, including 8MD/BMC modeling, for comparing the results across endpoints. An additional goal of this work is to investigate the behavior of the hybrid approach described by Gaylor and Slikker (1990) and elaborated by Cnamp (1995) for modeling changes in the mean response of continuous endpoints, but defining BMDs/BMCs in terms of probability of response. In particular, tile hybrid approach was evaluated in the context of considering biological significance on an individual basis. To those ends. tillS paper discusses modeling of short-term and cI.ronic inhalation and <X"al exposure to tI.ree nickel compounds, nickel subsulfide, nickel sul- CO8tinuou. eIIdf)Ojj)II (e.I., body weights) Ire dIOse for which "aMlIIlI" do not typically awly. ~nailative reIpoIIse data flX'such endpoirMS Ire _1-faccooly expascd in Ienna of a mean aM a 8taIMi8l1l ckviaI,iQII (IX' other measure of variabilily) fIX' e8Ch dose ~.
M~
Mu-.~ .-eIJ.,. 11Ie quaJIta1 ~ were modeled using d1e standanI Weibull aM polynomial modeIl (Crump, 1984) . A "t~" (i~) p8I8tnrAer was iacludcd in the nI(MieIiJlg OIIly we-a sufficient number of dole IJOUPS were available (at least four) and when thẽ without a ~ jXOvided a relatively poor ru 10 d1e "a. 11Ie degree of the polynomial ~I was ~cted 10 be DO greater than the number of dole &JOUPS miIHIS ~. The soflware pacblC8 11IRmH -11IRFSHW (ICP K8iser Intematioaal, KS Crump Group), which fit the modell by methods of muinwm likeJilM)(xj, were used to ~t these models. For the contilluws endpoints, we used the "hybrid" modeling 8pproacll deIcriJed by Gayklr and S1it.ta ' (1990) 
pJexp{ where ~ 1 is the inverse normal function.
The power model was also used to model continuous endpoints:
where m(d) is the mean ~ at dose d and die ~ unknown parameters. Q, /3. and k, as well as the dose group standard deviations. are estimated by maximum likelihood mdhods. The dose group swxIard deviations estimated by the model account 00th for dte variation in dte observed data and for any difference between the observed mean and the mean estimated by the model. The parameter k is not constrained to be an integer. but it is constrained to be grearp;r than or equal to 1. The underlying change in probability of response as a function of dose induced by Eq. (4) (assuming nonna! variation around dte dose-specific means and a COIIStaDt variaJK:e) is were applied to the body weight endpoint\ and used to predict the doses for which there would be a 10% change in mean weight This approach was implemented using the 1HC and THWC programs (lCF Kaiser International. KS Crump Group) . The BMDs derived in this approach <k> not correspond to specified changes in the probability of response. Rather. they correspond to doses for which the relative change in mean rcspoose ([m(d) -m(O»)/m(O» is 0.10. regardless of variability around the means. Moreover. because individual body weight data were available from one study (American Biogenic! Corp<>-rMia1. 1988 ). the \)(xIy weights were quantalized (considered abnonnal if they were below a chosen Xo and normal otherwise). and the counts of abnormal body weights were modeled using the quantal Weibull and polynomial models.
For the quantal models. goodness of fit was determined using the ;x2 lest. For the continuous models, goodness of fit was determined using an F test that the differences between the observed and predicted means (using variabilities observed within ~ groups) and accoonts for the degrees of freedom associated with the predictions and those associated with the withingroup variability.
A likelihood ratio test was performed to determine if consideration of dose-specific standard deviations significantly improved the fit of the power model to the continuous eIKipoints. When no significant improvement was found (p > O.OS), only results corresponding to the power model with constant variance were presented.
RESULTS AND DISCUSSION

Choice of Studies and Endpoints to Model
Studies. Studies were selected for modeling based on the quality of the study design, the biological significance of the endpoints observed, and the suitability of the data presentation for modeling. At least three exposure groups were needed, to better establish the shape of the dose-response curve. The study report needed to adequately define the protocol, including the nickel compound studied, the dosing or exposure duration, and the size of the dose groups. Quantitative response data (see Methods for Modeling) were also necessary. For inhalation studies, the MMAD and 0" g were also required for dosimetric adjustments (Jarabek et aI.. 1990; USEPA, 1994) .
The inhalation studies satisfying these criteria constitute a series of related reports of the effects in male and female F344/N rats and B6C3Fl mice of inhalation exposure to nickel subsulfide, nickel sulfate, and nickel oxide for subacute, subchronic, and chronic durations. These studies include Dunnick where N is die alrnUlative nomIal fulx:lion, ~ I is its inverse. aIKi (Tis die d eviation assumed for all dose levels. This fonn is for those cases in which valta of die CIx!poiIIt are adv~; a similar tXIU8IiOII hoIck for those cases in which ~ values of die endpoint are coosi~ ;Mjvene. The Wcibull and power nxxIeIs for continuous endpoints were fit using the softwJ XograIn BadLC (lCF Kaiser InIematiooa1, KS Crump ~) .
Use of the Wcibull or power models for continuous endpoints ~uires definition of a background incidence of abnormality, Po. or the specification of a level of response that can be considered the cut-point betWeen nonna! and abnormal responses, Xo' Specification of Po (and of the type of distributionassumed here to be nonna! for all endpoints) implicitly defines a cut-point, Xoo wilen the parameters for the background variability arc estimated as pan of the modeling. Similarly, specification of a cut-point determines the background incidence once the background variability is estimated (Crump, 1995) . 11te BMD is then defined as the lower bound on dose at which the iocreased probability of an abnormal response is equal to 10% (see below). In the absCIK:c of endpoint-specific toxicology data to support a ctxIice of a Po CK an Xo value, we examined a range of Po values (0.001, 0.01, 0.05) to evaluate the sensitivity of the predicted BMD to the selection of Po. The cut-point, Xo' was specified only in the case of models applied to body weights [data from Ambrose tt aI. (1976) , and American Biogcnics Corporation, (1988) ].
The continuous form of the Weibull model used here assumes that the sw1daId deviation is constant for all tkJse groups. The power m!.tel was run either assuming a constant variance or allowing dose-specific standard deviations. Although the standard deviations do not appear explicitly in the power model [Eq. (4)], d1ey are also estimated and affect estimates of the probability of response [see Eq. (5») . In the Research Triangle Institute (1988) study, the study authors did not state whether the reported measures of variability were standard deviations (SDs) or standard enon (S~); S~ were assumed for the modeling.
The belK:bmark response (BMR) considered in these analyses was 10% exn risk.. That is, die BMD for any particular combination of endpoint, model, Po, etc., is defined as the lower bound on the dose, dm, for which~3
For the continuous endpoints. doses ~g to 10% additional risk rather than 10% extra risk were calculated. Because the assumed background ratesrelatively low (less than S% when estimared directly and less than 14% when detcnnincd from the specification of a normaJ/abnonnal cut-point.
.to> there will be very little difference between extra and additional risk for thcsc endpoints. and thus little difference between the BMD estimates derived here and those conesponding to 10% exm risk. Table I lists d1e ~ sensitive quanta) and C(rtinoous endpoints fnM11 ~ inhaIatioo studies of nickel ~~.
When one sex was clearly more sensitive, due to a higher quantal res{K)I1se at die ~ HOC or a k>wer fIOC for die satre ~ level, only t~ results f~ ~ more sensitive sex are (Xesented.
Subacute subsuljide. Acceptable fits were obtained for the modeling of olfactory epittaelial atropIlY of male and female rats ex~ to nickel subsulfide, with a slightly lower BMC calculated for males (Fig. I , Table 2 ). The lung inflammation endpoint (see Table I ) was modeled for the information it provi(b) on the upper bounds, rallaer than to obtain the MLE or BMC. Because lung inflammation was observed in 100% of llae males and females at all ~itive exposure levels, no unique maximum likelihood estimates exist (e.g., in dIe Weibull model, the parameters a, fI, and 'Y could not be uniquely estimated). The lower bound on concentration COITCSponding to any BMR for this endpoint is 0; the upper bound on the concentration COn'eSponding to 10% risk: of lung inflammation was 0.034 mg Ni/mJ (Weibull m<xIel) and 0.016 mg Ni/mJ (polynomial model) for both males and females. 111e significance of llae upper bound for comparisons among the different nickel compou~ is addressed below.
Subacute sulfate. A 100% response was observed for olfactory epithelial atrophy and lung inflammation in females and males following subacute exposure to nickel sulfate. Because the HOC values for males were hig~r IIlan those for females for die same exposure levels and the response was tile same, the results from males are not presented. f'or iK)th of dJese endpoints, the BMCs determined from such minimal data sets would be zero. The upper bounds on concentration co~-sponding to IOIJ, risk for the females were 0.011 mg Ni/mJ (Weibull model) and 0.0054 mg Ni/mJ (polynomial model) for the nasal endpoint. For the lung endpoint, the upper bounds for females were O.~ mg Ni/mJ (Weibull model) and 0.032 mg Ni/mJ (polynomial model). Different upper bounds were obtained for the two endpoints due to die different dosimetric adjustments for die extrathoracic and pulmonary regions.
Subacute oxide. The concentration-response curve for alveolar inflammation following subacute exposure to nickel oxide was also quite steep, increasing from 0% at 3.9 mg Ni/mJ to 100% at 7.9 mg Ni/mJ (Table I) . Although the alveolar inflammation response jumped from 0 to 100%, a BMC can be calculated for this endpoint, because there were positive exposure levels below the level that induced a 100% response. Interestingly, the BMC is less than the highest concentration for which 0% response was observed (0/5 responders observed at the NOAEL(HEC] of 0.42 mg Ni/m3, versus a BMC[HEC) of 0.34 mg Ni/mJ). This result is consistent with the fact that the observati~n of 0 responders out of 5 animals on test is in no way conclusive evidence that no risk exists at that exposure level. In fact, if the risk: (probability of response) at that level of exposure were 0.10, one would expect to observe a response rate of 0/5 almost el al. (1988, 1989) , Benson el al. (1987 , I~), Lovelace Inllalation Toxicology Research Institute (1986a , and N'J1» (l996a.b,c). Exposures were conducted for 6 II/day, 5 days! week. for 16 days (12 exposures) in tile subacute studies, for 13 weeks in the subchronic studies, and for 2 years in tIle chronic studies. Because of slight differences in the repoc1ed response rates among these studies, the NTP data were considered for modeling because more detailed infonnation on the responses and particle characterization was provided in the NTP repoi1s. The MMAD for all of the NTP studies was in tile range 1.9 to 3.0, and the 0'. ranged from 1.9 to 2.4. Respiratory effects were the most sensitive endpoints. Mice were less sensitive than rats to respiratory effects of inhaled nickel compounds, although they were more sensitive to the lethal effects of nickel subsulfide and nickel sulfate (N1V, I 996a,h). This paper concentrates on the more sensitive species, and tllerefore does not discuss results in mice.
The oral studies satisfying the criteria for modeling include two subchronic studies (American Biogenics Corporation, 1988; Dieter et al.. 1988 ) and one chronic study (Ambrose el al.. 1976 ). While Dieter et al. (1988) focused on immune system responses, tIle other two investigations looked for genCl'81 systemic effects. In addition, two reproductive toxicity studies (Research Triangle Institute, 1988; Smith el al.. 1993) were considered adtXJuate for analysis.
Endpoints. The biological significance and adversity of the endpoints in the selected studies is an important consideration. As an examflle, for the three compounds under consideration, all tile inhalation ex(lOSures for most of the exposure durations induced alveolar macropllage hyperplasia (at 100% incidence at the low concentration in at least one species/sex in many of the studies). Although this is a sensitive endpoint, it was considered to be "fire-adverse," as it consisted of a sligllt increase in the number of alveolar mac£O(lhages and was described as only subtly different from controls. Sucll slight increases in macrophage number can also be seen with nuisance dusts, although the low exposure concentration laere and tile differences observed with nickel exposure between rats and mice indicate that the effect is compound-related. Nevertheless. because this effect was considered "pre-adverse," it was not modeled.
The final step in choosing endpoints appropriate for modeling is to identify the more sensitive of the biologically relevant endpoints for each exposure duration and nickel compound. For inhalation experiments, that detennination is made after adjustments for intennittent exposure and after calculation of the HECs (see Methods for Modeling), in order not to miss tile endpoints that would aPf'8£ently be more sensitive in humans ex(lOsed continuously. The endpoint(s) with the lowest NO-AEL(HEC) and/or LOAEL(HEC) were selected for modeling. In addition, the magnitude of the response (especially for quantal endpoints) is considered in choosing the most sensitive endpoints. BMD defined in terms of a probability of response for this continuous endpoint (Crump, 1995) . Because little infomlation is available on the modeling conditions that correspond best to NOAELs, several different combinations were explored. Thus, BMRs of 5 and 10% were determined, using values of 0.001, 0.01, and 0.05 for the background incidence of a lung weight 60% of the time. The BMC, which is represented by a confidence limit, correctly reflects that possibility. Nickel ox-ide also induced a gradual increase in lung weight at all exposure levels (Dunnick et al., 1988) , becoming significant in a pairwise test at 7.9 mg Ni1m3. This continuous endpoint was modeled using the "hybrid approach," with the Fig. 2 ).
Subchronic sillfale. Modeling was conducted for d1e subchronic studies with all three nickel compounds, but only data related to the subchronic study with nickel sulfate are presented (Table 4) . Of Ihe three compounds tested, nickel sulfate was the most toxic following subchronic exposure (data not sllOwn). Only one endpoint. olfactory epitllelial atrophy in femaJe rats, was modeled for dte subchronic study of nickel sulfate. The fit was excellent (p = 0.96), and the BMC was 4.8B-. mg Ni/m3 (Fig. 3) . UnceI1ainty in tI~ modeling is relatively low, due to the presence of three nonzero data points in the low-exposure region (Table 1) .
Chronic subsulfide. Because there were only high rates of response for most of the effects observed after chronic exposure to nickel subsulfide, die only modeling pursued was for olfactory epithelial atrophy. An excellent fit was obtained (Table 2) , and the BMC(HBC) for that endpoint (0.01 mg Ni/m3) was similar to the HECs COITesponding to high response levels (91 to 100%) for the other endpoints (0.009 to 0.01 mg Ni/m3; see Table 1 ). That is, the lower bound on c orresponding to a 10% risk of olfactory epithelial atrophy is nearly the same as the dose observed to yield high rates of lung effects. Not surprisingly, these modeling results do not alter the impression that die most sensitive endpoints were chronic active lung inflammation and lung fibrosis. the lowest positive exposure level, and there was a high background incidence of response for all endpoints. The BMCs for such endpoints are subject to great uncertainty because of a lack of infonnation about the concentration-response behavior, and would be equal to zero for endpoints with a 100% response at all nickel oxide concentrations tested.
Information on dose-response relationships. There are several related weU-cooducted snJdies addressing the inhalation toxicity of subacute, subchronic, and chronic exposure to nickel subsulfide, nickel sulfate, and nickel oxide. As shown above, however, there was little or no infonnarion on the shape of the exposure-response curve for many of the fiK)St sensitive endpoints from these studies. For many of the endpoints, the lowest concentration gave a response incidence at or near 100%. Thus, for nickel sulfate provided useful information on the shape of the COlK:entration-response curve in the low-<:oncentration region ( Table I ). The modeling results for those endpoints (Table 4) show that inclusion of a "threshold" (intercept) parameter in the models (and the restriction of the power parameter to its limiting value of 1) improved the fits in many cases and was required in order to obtain adequate or marginal fits in some cases (see Fig.  4 ). Note that the threshold parameter is purely a statistical parameter, and is not necessarily related to a true biological threshold The tlueshold parameter bounds the region of the dose-respoose curve where the model estimates the same response as background for the observed effect. 0.00 1.00 X 100 1.04 X 10-3 7.33 X 10-1 7.33 X 10-1 1.12 X 10-) 7.25 X 10-4 1.12 X 10-) 7.25 X 10-4 2.22 X 10-) 1.70 X 10-) 1.38 X 10-) 8.35 X 10-4 2.69 X 10-) 2.31 X 10-) 1.46 X 10-3 9.29 X 10-4 3.8> X 10-) 2.83 X 10-) 3.21 X 10-) 2.55 X 10-3 3.45 X 10-) 2.50 X 10-) 3.45 X 10-) 2.50 X 10-)
1.11 X 10-1 1.11 X 10-1 3.21 X 10-2 1.M X 10-3 1.06 X 10-3 0.00 1.00 X 100 1.62 X 10-2 3.21 X 10- example, an extrapolatioo from ~ response in die study to 1 r espoose (i.e., 1~ extra risk) was re(Jrnrro for olfactory q>idJeliai atrophy in male rats following subacute nickel su~ulfioo exposure. One advantage of die BMD methodology is dIat il can re used to identjfy a BMD when a study does not identify a NOAFL (Crump, 1984; Allen et aL, 1996) . Never1Jx-;less, large unoortainties are associated willi data sets lacking infonnation 00 die shape of die ~ponse cwve in die region ~ response ~ are similar to die BMR of in~ This may re one reason Bames et al. (1995) cautiooed against extrapolating from high to low response rates. In dtis case, die lo~ positive exposure concenntion differed from the best estimate of dJe concentration associated with 10% response (die Ml.E) by n1(Xe than a factor of 10 ( Fig.  1 . Table 2 ).
Such uncertainties contribute directly to the size of the confidence limits around best estimates. The exlreme examples are dIOSe instances (e.g.. lung inflammation after subacute exposure to nickel subsulfide) where 100% of the animals 
CG~-.~-. "-AF IG. 3. Gnpbical display or die reaulta of benclunart modeling using die Weibull nMJdel (-) and polynomial model (--.) ror olflCtory epithelial atrophy in remale rats exposed to nickel sulrate ror . subchronic duration. responded at the lowest positive dose. In those cases, there is absolutely no infonnation on the shape of the dose--response curve between 0 response and 100% response. As a consequence, unique maximum likelihood estimates do not exist, and the lower confidence limit on the dose corresponding to any response level is O. The statistical methodology is consistent with the toxicological uncertainty; the dose associated with any particular response level is unknown.
Note, however, that the level of response at the lowest positive dose is not the only, and perhaps not the major, factor determining the size of the confidence limits. In the case of atrophy of the olfactory epithelium following subacute exposure of female ral~ to nickel subsulfide, the response at the lowest positive dose was 40%, half the response rate observed for the same endpoint in male rats (see Table I ). For the females, the MLE for a 10% response was less than a factor of two below the lowest exposure level (the LOAEL(HEC]), and the BMC was about a factor of 6.5 less than the MLE. For males, the MLE was more than a factor of 10 less than the LOAEL(HEC), but there was only a 1.8-fold difference between the MLE and the BMC. The reason for the difference in the ratios between the MLE and BMC for these two data sets is that the best estimate (i.e., the MLE) of the shape of the dose-response curve for females was nonlinear, while the MLE curve was linear for males. By contrast. linearity could not be ruled out in either case, leading to a linear lower bound (related to the BMC estimate) for both sexes. The difference between the nonlinear best estimate and the linear lower bound (as observed for females) is associated with a larger MLE: BMC ratio than if the best estimate and the lower bound had both been based on linear concentration-responses. Thus, although the large response at the lowest positive dose observed for the males might be expected to lead to large uncertainty (i.e., big differences between the MLE and the lower bound), larger differences can appropriately arise simply because of the shape of the dose-response curve.
An interesting contrast is provi<bl by the data for subacute nickel oxide alveolar inflammation of the lung in females. For that endpoint. d1e response rate also jumped from 0 to 100% widt no observed intermediate responses. However, that increase did not occur until the fifth of six exposure groups. As in all the cases widt no observed intermediate response rates, the MLE of the concentration corresponding to 10% extra risk is not unique. Nevertheless, a lower bound on that concentration can be calculated (for any particular m<xtel) and that lower bound is not zero. It is lower than the highest concentration for which 0% response was 0b-served (0.34 mg Ni/m3 vs the NOAEL(HEC) of 0.42 mg Ni/m3) because of the uncertainty associated with the relatively small. but not necessarily zero, probability of response at that NOAEL-(HEC). Particularly in light of the small sample size, the data set available is not sufficient to rule out 10% response rates below the NOAEL(HEC). dial exlra(x>lates from a ~ dlat pOOuccs I~ I'eSfXJnse would be problematic, and might be a reason ~ to derive sudl a value. If a ~ pOOucing 100% resfX)ILo;e were used as dte basis for an RJL' or RiD, coosj(boabIe toxicok>gical judgeor.nt wookJ be required to evaluate dte ~~ W)CeI1ain(jes. Infonnation on dte severity of dte re8IXJIl8e woold be an impoc1ant factor in assessing dlis issue. As for dte bencIunart approach, knowl~ge of dte shape of dte ~~ cwve is useful. In dtis case, dte sIeq> eXJXNI~ ~oo f(X" nickel sulfate may su~ dlat dte ~ wookJ also ~ rapidly from dte high resfX)nses d:lServoo with the (Xher COI11(XXInds, and the NOAEL migllt t te mld11ower than dte lowest OOI:k:entration cestOO. Nd te quality of a risk ~~t for nickel sam.1ftde and nickeJ oxioo would be markedly imaxovoo by toxicity data at lower f'eSIx>nSC levels.
Hybrid modeling of continuous endpo;nIs. The continlKXlS endpoint ~oo after subocute inhalation of nickel oxiOO was Ioo using the "hybrid approach." widl dte BMD definOO in terms of a probability of resfX)nse. The BMDs (for fix~ BMR) for smaller values of Po are greater than those for larger values of Po. This arises as a result of the shape of the normal distribution assumed for the variability of tile res(X>nses, the so-called "bell-shaped" curve. The Po value s~ifies how far out in dte tail of the distribution the adverse response is: for smaller Poo fewer unexposed animals are considered to be in the abnonnal range. As dose changes, we are basically considering shifts in the distributions; the mean value for the endpoint that is being measured cl1anges to reOect the shift to more adverse effects, and more of the tail of the distribution enters into the abnormal range. For a given change in the mean, tltere is a larger change in response for Po = 0.05 than for Po = 0.001 (because the slope of tlte rell curve is greater at larger PO>. Stated another way, a smaller change in the mean is necessary to produce a given Increased risk (e.g., a DMR of 10%) for a larger Po. Since the response is being measured relative to untreated animals, a small change in mean corresponds to a lower dose.
Note also the differences in the model-predicted ML& and BMCs for fixed Po and BMR. The differences between the model predictions provide some indication of dIe model unceI1ainty or model-dependency of the dose-response modeling results. A part of that model dependency is explain~ by the fact that the continuous Weibull model ~Iows plateauing, while the power model does not. Generally, dIe further away from dte experimental doses the DMDs are, the greater tile model dependence. ll1is lower hound might he meaningful for some risk: assessment purposes. For example, the lower hound for tlte most sensitive subacute nickel oxide endpoint is larger tllan tile u~ hound for all of the OK)St sensitive subacute nickel subsulfide and nickel sulfate endpoints (the largest upper hounds are 0.034 mg and 0.066 mg Ni/m3 for the subsulfide and sulfate, respectively). In other words, nickel oxide was significantly less toxic than the other two compounds in the subacute study, as detennined by a comparison of concentrations COITeSponding to 10% risk. a finding that should be usable in a comparative risk analysis. Clearly, in this case, where the number of exposure groups and the HEC values themselves are very similar ac~ compounds, a model-based comparison of this nature may not be required to reach consensus on relative rankings of toxicity. However, other situations may occur for which cross-compound differences in dose levels, spacing between ~, and numbers of <k»ses tested make quick-anddirty NOAEULOAEL comparisons unsatisfactory.
The above discussion dt>es not imply that the lower bounds calculated for these endpoints with liule or no infonnation about tile shape of the doso-response curve can or slK)Uld be used for all purposes, especially for setting regulatory exposure limits. In fact, the data that are available for subacute exposures cannot identify the OK)St sensitive endpoint for any compound. Thus, whereas smaller dose-level extnpolations (e.g., from 20 or 40% incidence) may be approf)riate, extrapolation from higher response levels (e.g., from 80% incidence or greater) to a BMR of 10% should be avoided.
On t~ otller hand, related studies may provide relevant information on the shape of the dose-fesiX)n5e curve in some situations, and allow modeling in otherwise problematic instances. For example, the respiratory endpoints for chronic niclel sulfate exposure exhibited a more gradual increase at low concentrations, followed by a steep increase; these data were best fit by models tl18t incorporated a "thresI1OId" parameter. llle infonnation on the shape of the concentration-'-response curve for nickel sulfate could not be incorporated into tile m<xIeling for chronic nickel subsulfide or nickel oxide responses, because there were no data related to tile size of a relevant "tllresI1OId" value for those compounds. It might be appropriate to use lnowledge of the similarities of these three compounds to detennine if a "threshold" similar to that observed for niclel sulfate would be expected for tile other two compounds. If so, then that infonnation could be used in conjunction with the observed concentration-response data for subsulfide and oxide to constrain tile allowable concentrationresponse curve shapes. That was not done here and the bestfitting concentration-response models for chronic subsulfide and oxide exposure all predicted relatively steep concentration-response behaviors starting immediately above zero concentration. These results were considered to be no more useful than the LOABLs.
The concerns raised here about extrapolating from high re-S[X)nse levels also apply, at least to some degree. to the NOAFli LOABL met11Od. Calculation of an RfC or RtD by any ~ 223 NICKEL AND BENCHMARK MODELING ISSUES Assuming nonnally distributed variability, the combination of a Po of 0.05 and a BMR of 0.1 is equivalent to defining the BMD as the lower bound on dose that results in a change in the mean response equal to 0.6 times the standard deviation (Crump, 1995) . Kavlock et al. (1995) found that. for a fetal weight endpoint, a BMR defined as sdJ2 yielded BMDs that were on average similar to the corresponding NOAELs for a set of developmental endpoints. Thus, in the absence of additional infonnation (e.g., toxicological consensus on what values of a continuous variable constitute abnormal or adverse observations-that is, on the definition of "biologically significant" changes), the combination of Po = 0.05 and BMR = 0.1 might be an appropriate choice to use with the hybrid approach for dose-response modeling of continuous endpoints.
low-body-weight animals, and modeling using the hybrid approach that predicts the probability of low-body-weight animals based on the variability around the mean. There are some differences in the maximum likelihood estimates of the dose corresponding to a 10% increase in incidence that depended on whether the data were quantalized before modeling or treated as continuous observations. Although the same Weibull model was used in both approaches, different MLEs were obtained due to slight differences in the maximization of the likelihood for the two approaches. In the case of the quantalized data, the likelihood that is maximized is the product of the dose-specific probabilities of observing the quantalized results, which is based on binomial probability theory. For the continuous data, the likelihood function involves differences between the observed means and the implicit function for the change in mean as a function of dose [see Eq. (3)] and is based on normal theory. Although asymptotically (for large sample sizes) one might expect these two approaches to converge, for the sample sizes available, there were !!ome apparent differences. The BMD estimates (representing lower bounds on the maximum likelihood estimates) show much closer agreement.
Draft U.S. EPA guidance (USEPA, 1996b) and a peer review of that guidance (USEP A, 1996c) have recommended that biological significance should be the preferred basis in the choice of the BMR. The body weight results provide a particularly relevant basis for starting to carefully consider some of the issues associated with specifying biologically significant changes, where the concept of biological significance relates to the identification of a certain degree of change in a continuous measure that is considered indicative of abnormality or adverse response. At issue are questions concerning whether biological significance should be based on group-level observations (corresponding, in our analyses, to BMDs based on a 10% decrease in the mean body weight), which appears to be the commonly accepted practice, or on changes in incidences of individual adverse responses (corresponding to the hybrid approach).
The difference between these two approaches can be illustrated simply by assuming a symmetrical distribution of body weight and that an effect on body weight is evenly distributed in the population. In this case, a 10% decrease in the mean corresponds to a 10% decrease in body weight for 50% of the animals. A dose that affects 50% of the animals is almost certainly greater than a dose that causes the 10% increased risk that is the basis for the BMR in the hybrid approach. As expected from this analysis, BMDs based on current toxicological practice (i.e, a 10% decrease in the mean response being adverse) resulted in higher MLEs and BMDs than those estimated based on a 10% increase in the incidence of "Iowweight" animals (Table 6 ). (For the purposes of comparison, "low-weight" was defined to be 10% below the control group mean.) A BMD of 1.5-4.9 mg Ni/kg/day was calculated for the American Biogenics Corporation data when the BMR was defined in terms of a 10% increase in incidence of low weights. In contrast, the BMD was 17 mg Ni/kg/day (power model or polynomial model) based on a 10% decrease in the mean.
Modeling of Oral Studie.\' Toxicity data appropriate for modeling are available from chronic, subchronic, and reproductive and developmental studies employing oral exposure. Table 5 provides summary information about the studies/endpoints that were considered in this investigation. The chronic and subchronic exposures resulted in decreased body weight, pneumonitis, and/or immunotoxic responses. Prenatal and neonatal mortality increased following in utero exposures.
Body weight. Decreased body weight was modeled for a 2-year dietary study in rats with nickel sulfate (Ambrose et al., 1976) , and for a gavage study in which rats were dosed for 90 consecutive days with nickel chloride (American Biogenics Corporation, 1988). For both of these studies, several different modeling approaches were considered (see Methods for Modeling and Table 6 ).
Decreased body weight following subchronic exposure to nickel chloride (American Biogenics Corporation, 1988) could be well represented by the continuous endpoint models (Table  6 ; Fig. 5 ). The plateau of the Weibull model appears to be more consistent with the data, but, with only three dose groups, the linear representation provided by the power model cannot be ruled out. Satisfactory fits for both models were also obtained for decreased body weight data following chronic exposure to nickel sulfate (Ambrose et aL, 1976) (Table 6) .
Interestingly, lower BMDs were obtained in the subchronic American Biogenics Corporation study than for the corresponding model with the chronic Ambrose study. This difference may reflect higher toxicity of nickel chloride compared to nickel sulfate, or higher toxicity via the gavage route compared to dietary administration. Because the same differences were seen for the MLEs as for the BMDs, these differences do not appear to be driven by the uncertainty associated with lower bound calculations or related to dose-selection issues.
Because individual animal data were available for the American Biogenics Corporation (1988) study, the data were also quantalized using the same cut-point as used in the hybrid modeling, and modeled as quantal data. This allowed a direct comparison between modeling based on the actual number of . Average doses were about ~ lower during prebr~ing and &eslation, and about ~ higher during lactation, due 10 higller water consumption during lactation.
. Supported by results for other measures of pup deadI. The overall study NOAEL may be lower than 6.8 mg/kg/day, ~ on the other two measures of perinatal mortality, tMlt the identification of a NOAa is problematic due 10 the lack of a clear dose-rcsponse for dead pupsnitter at die low doses.
The average nickel consuDl{Jtion repotted by dte audlOrs variOO by more than a factor of 2, with dte higbest consumpjon at dte beginning of dte premaling exposure and during the latter part of the lactation period. As a cooservative estimate, dte exposure during &estation, which was on the low end of overall exposure levels, was used for modeling. This choice also lakes inlo account the possibility that gestational exposure alone could account for the observed effects.
Willie a 10% decrease in the mean body weight may be an adequate cutpoint for detennining when a group of animals can be considered adversely affected. it may be a poor indicator of a biologically significant change for an individual animal. Although this point is illustrated here using body weight data. similar problems are likely to arise in other attempts to use biological significance as the basis for the choice of BMR, because biological significance in animals is Qften defined in terms of changes at the group level, while tlte probability of an effect is modeled for an individual.
Consider also that the current definition of adversity for body weight is consistent only as an indicator of LOAELs c Quantal ~ling could not be cooductcd for Ambrose et aL (1976) . because individual anima1 data were not available.
(ignoring, for the sake of this discussion, the inconsistencies inherent in the LOAEUNOAEL approach that were mentioned in the introduction). The 10% decrease in mean weight identifies the point at which adversity (on a group level) has become apparent. If, as above, one contemplates the definition of a biologically significant cut-point that corresponds to a 10% decrease in mean weight, it may be the case that the resulting BMRs result in estimates (MLEs and/or BMDs) that are more like LOAELs than NOAEU. This point is illustrated by the two body weight data sets modeled for oral exposure to nickel. In the Ambrose et al. (1976) study, the NOAEL was 5 mg Ni/kg/day, with a 5% decrease in body weight. and the LOAEL was 50 mg Ni/kg/ day, with a 20% decrease in body weight. The BMD based on a 10% decrease in the mean was 36 mg Ni/kg/day. As expected, the BMD was between the LOAEL and the NOAEL, but it was closer to the LOAEL. In the American Biogenics Corporation (1988) study, the percentage decrease in body weight at the NOAEL (5 mg Ni/kg/day) was 5%, while the percentage decrease at the LOAEL (35 mg Ni/kg/day) was 18%. The BMD was estimated to be 17 mg Ni/kg/day. Even though the "conservatism" of using lower bounds in the definition of the BMD has already been incorporated, BMDs based on a 10% decrease in mean weight were higher than NOAEu and closer to LOAEu. A hybrid modeling approach and definition of a biologically significant cut-point that had as its goal the matching of a 10% decrease in mean weight would be expected to maintain a siInilar relationship to the NOAEU and LOAELs.4 Conversely, a BMD based on a 10% increase in the incidence of low-weight animals may be overly conservative compared to standard toxicological practice that defines adverse effects on body weight based on changes in the mean.
The most appropriate definition of the BMR for decreased body weight relative to controls, or for most continuous endpoints, has yet to be determined, but it is a crucial issue. Early applications examining developmental toxicity studies (Allen et aL. 1994a.b; Kavlock. et al., 1995) have defined BMRs to determine where there is a correspondence, on average, between NOAELs and resulting BMDs; it is not clear how those results will generalize to endpoints from other experiments. Little work has been conducted to systematically investigate the correspondence between different BMR definitions and NOAEU for studies on endpoints other than developmental toxicity. Haag-Gronlund et al. (1995) compared NOELs and LOELs reported by study authors for systemic toxicity and neurotoxicity of trichloroethylene with different BMDs, and found that 42% of NOELs were higher than the corresponding quantal BMDI0 (10% response) values. This correspondence is consistent with the results from the developmental studies.
Other endpoints. The models implemented for the hybrid approach to modeling the continuous Iympboproliferative effect (Dieter et al., 1988) were generally unsuccessful in representing the observed dose-response pattern, as indicated by the low p-values associated with goodness of fit for that endpoint (Table 7) . The discrepancies between the observed and predictcd mean responses occurred mostly at the higher dose levels.
The prenatal and neonatal mortality data were fit well by the models, whether the data were available in quantal fonn (number of litters with dead pups, Table 8; Fig. 6 ) or continuous form (percentage mortality per litter, Table 7 ). For the latter representation, the power model provided a clearly superior fit, .. This is because. for a standard study design, if~ MLE bas as its tuget 8 10% chanae. ~ lower bound, ~ BMD. will still be associated fairly consistently with pcn:cntage changes in bOOy weight only slightly lower. maybe 7-8. decreases. (Table 7) . In Uus case, the lower bounds appear to be more stable to choice of model. The prenatal mortality endpoint appears to be almost as sensitive an indicator of the toxicity of oral nickel chloride exposure as decreases in body weight-the MLEs and BMDs for tlle latter are only slightly less than those for tile former.
CONCLUSION
This paper illustrates some of the issues and problems that may arise in conducting a noncancer risk assessment that allows such endpoints to be compared directly to the quantal endpoints, in terms of the risks of adverse responses at particular doses or concentrations. The data set available for various nickel compounds is extensive and complex. By considering several nickel compounds together, we have been able to consider cross-chemical similarities and differences. Particularly noteworthy were the similar responses and concentration-response patterns that were seen for nickel subsulfide and nickel sulfate in the subacute studies. Even though infonnation on dose-response relationships was sketchy at best, BMCs corresponding to a fixed level of risk were capable of rank ordering the respiratory toxicity of the oxide compared to the subsulfide and sulfate compounds, and were consistent with toxicological judgment.
Difficulties arise when the lowest response rates are at or near 100%. Because such observations provide little or no infomlation about the shape of the dose-response curve, the most appropriate interpretation of those observations is not clear. Such data sets are quite problematic for both BMD and NOAEUl..OAEL methods and best handled by the acquisition of additional toxicity data. However, both approaches could benefit from data from other sources regarding the shape of the dose-response curve.
Also noteworthy were the patterns observed in the chronic inhalation studies. Again, simi}ar endpoints were observed for all three compounds. In this case, however, similar concentration-response pa~erns were observed for nickel subsulfide and nickel oxide (at or near 100% response at all nonzero exposure levels). The observed nickel sulfate concentration-response pattern, based on testing conducted at lower exposure levels, provided much more infOmlation about the shape of the concentration-response relationship, with at least one exposure 4.97 x 100
1.76 X 10-1.05 X 101 10% extra risk Smith et at. (1993) Number of litters with dead pups chemical-specific HMO investigalions. Because there are always case-specifIC considerations affecting the application of the BMO approach, such analyses are wOl1hwhile and informative. Moreover, in the course of such assessments, one identifies issues related to BMD applications that have more general implications. We have addressed some of the issues tllat were salient to the analysis of nickel (e.g., cross-chemical and cross-endpoint comparisons, choices associated with the definition of the BMO for continuous endpoints, and, more specifically, tile considerations appropriate to the incorporation of "biological significance" for that definition). The resolution of these issues can be accelerated by the accumulation of a number of case studies, such as the one presented here, for which analytical options are compared and tested against toxicological judgment.
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evel showing little change from control and another exposure level associated with a moderate response level. It would be fruitful to investigate the possibilities for integrating information on dose-response patterns for closely related compounds, such as tltose considered llere.
Because of die aforementioned difficulties, the identifICation of a princi(}81 study and critical endpoint f(X the «b1vatioo of a nickel RfC is problemmic. HoweVeA", f(X dwnic ex~ nickel sulfatẽ to 00 die ~t toxic (X comparable to die ~ toxic of the d1ree coolpOUnd'i. Nickel sulfate IWOdaJa"Ai ~ ooIy slightly lower than ~ resulting from nickel subsulfide ex~re, at HEC valta aboot half the lowest ~ ~ of nickel subsulfide. Nickel oxide concen~ r-utiucing axn.-rable re8(X)nses were much higher. Therefore, a nickel R«:' could be derived based 00 the ~ sensitive nMC f(X chrooic ex~ to nickel sulfate, 1.7 X 10-3 mg N"J/m3 f(X lung fi~is in male rats. (The appIicatioo of ulx:atainty factm aIMI ultimate RfC calculation are not IWJdressed here.) The BMC calculated f(X oIfẽ pithelial ~y in female IWs following suldMOOic exw as a factor of aAWximately 3 lower (4.8 X 10-4 mgNi/rn3), oot the re8IXXlse incicblCe f(X dtis endpoint was lower in the ctuooic study, suggesting d1at recovery may have (X:CUnOO. An 8(ktitiooal reason that nickel sulfate may be more appropriate than nickel Iflde as the ..is f(X the nickel R«:' is dial nickel sulfate is a more environmentally relevant ~nd.
A case could bẽ dial nickel oxide is less toxic, and a less C(:M1SerVative R«:' may be ~ate f(X nickel oxide. However, ~ eXJX9lre-respoose data in die low~tration regioo would be needed to sulJlX}rt a sepal3te RfC f(X nickel oxide.
Identification of an appropriate basis for the nickel RfD is not as difficult. Approximately eAluivaient sensitivity, in tenns of the values of the nMOs, was observed for the developmental and systemic endpoints; a BMD of 4.1 mg Ni/kg/day was calculated for decreased lyrnpi1oproliferative response in female mice exposed for 180 days (Dieter el al., 1988) , and a BMD of 4.97 mg Ni/kg/day was estimated for increased number of litters with dead pups in the first generation of a two-generation reproductive study (Smith el aL, 1993) . These values are consistent with the BMOs derived for other oralexposure endpoints, wluch range from about 1.5 mg Ni/kg/day for some versions of the body weight analyses to 25 mg Ni/kg/day for the (apparently) less sensitive neonatal mortality endpoints (RTf, 1988) . The BMOs differ by only about a factor of 2 from their corresponding MlEs and thus there is no suggestion that tile values of the HMOs are artifacts of poor data. Because Dieter el al. (1988) considered the decreased lympi1oproliferative response to be an effect secondary to effects on the myeloid system. the HMD associated with the direct developmental effects (prenatal mortality) might be preferable for regulatory purposes. In any case, a HMD of about 4 or 5 mg Ni/kg/day (a value not inconsistent with the NOAELs reported by various study authors) would be appropriate for regulatory application.
Note, in closing, tllat this analysis of nickel compounds has been done in the context of several, more or less indef'lendent, 
